Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 138, 111459
Abstract
No abstract availableKeywords
Funding Information
- European Commission (18-00121S, ÚNKP-20-3-II, -16-2016-00004, EFOP-3.6.1)
- Grantová Agentura České Republiky (18-00121S, ÚNKP-20-3-II, -16-2016-00004, EFOP-3.6.1)
- National Research Development and Innovation Office (18-00121S, ÚNKP-20-3-II, -16-2016-00004, EFOP-3.6.1)
- European Social Fund Plus (18-00121S, ÚNKP-20-3-II, -16-2016-00004, EFOP-3.6.1)
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap (18-00121S, ÚNKP-20-3-II, -16-2016-00004, EFOP-3.6.1)
- Ministry for Innovation and Technology (18-00121S, ÚNKP-20-3-II, -16-2016-00004, EFOP-3.6.1)
This publication has 70 references indexed in Scilit:
- Preparation of silybin and isosilybin sulfates by sulfotransferase from Desulfitobacterium hafnienseJournal of Molecular Catalysis B: Enzymatic, 2013
- Human serum albumin: From bench to bedsideMolecular Aspects of Medicine, 2012
- Effects of Silibinin on the Pharmacokinetics of Carvedilol after Oral Administration in RatsJournal of Pharmaceutical Investigation, 2011
- Two Flavonolignans from Milk Thistle (Silybum marianum) Inhibit CYP2C9-Mediated Warfarin Metabolism at Clinically Achievable ConcentrationsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Significance of Protein Binding in Pharmacokinetics and PharmacodynamicsJournal of Pharmaceutical Sciences, 2010
- Multitargeted therapy of cancer by silymarinCancer Letters, 2008
- The interaction of silibinin with human serum albumin: A spectroscopic investigationJournal of Photochemistry and Photobiology A: Chemistry, 2008
- Quantitation of Silibinin, a Putative Cancer Chemopreventive Agent Derived from Milk Thistle (Silybum marianum), in Human Plasma by High-Performance Liquid Chromatography and Identification of Possible MetabolitesJournal of Agricultural and Food Chemistry, 2007
- Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic ConsequencesClinical Cancer Research, 2006
- SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASESDrug Metabolism and Disposition, 2004